FI783175A7 - Imidazol-derivat och salter daerav, deras syntes och mellanprodukter och farmaceutiska preparat - Google Patents
Imidazol-derivat och salter daerav, deras syntes och mellanprodukter och farmaceutiska preparat Download PDFInfo
- Publication number
- FI783175A7 FI783175A7 FI783175A FI783175A FI783175A7 FI 783175 A7 FI783175 A7 FI 783175A7 FI 783175 A FI783175 A FI 783175A FI 783175 A FI783175 A FI 783175A FI 783175 A7 FI783175 A7 FI 783175A7
- Authority
- FI
- Finland
- Prior art keywords
- och
- farmaceutiska
- syntes
- deras
- preparat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4351277 | 1977-10-19 | ||
| GB4353277 | 1977-10-19 | ||
| GB398478 | 1978-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI783175A7 true FI783175A7 (fi) | 1979-04-20 |
Family
ID=27254350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI783175A FI783175A7 (fi) | 1977-10-19 | 1978-10-18 | Imidazol-derivat och salter daerav, deras syntes och mellanprodukter och farmaceutiska preparat |
Country Status (12)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| JPS6047257B2 (ja) * | 1979-07-19 | 1985-10-21 | 旭化成株式会社 | 新規な塩基性物質およびその製造法 |
| US4430445A (en) | 1979-07-19 | 1984-02-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin |
| JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
| GR78234B (enrdf_load_stackoverflow) * | 1981-03-10 | 1984-09-26 | Ciba Geigy Ag | |
| JPS57188570A (en) * | 1981-05-14 | 1982-11-19 | Shionogi & Co Ltd | Benzylazole derivative |
| JPS5953470A (ja) * | 1982-08-14 | 1984-03-28 | ザ・ウエルカム・フアウンデ−シヨン・リミテツド | イミダゾ−ル誘導体 |
| US4581370A (en) * | 1983-07-12 | 1986-04-08 | Schering A.G. | Antiarrhythmic imidazoliums |
| JPH0172006U (enrdf_load_stackoverflow) * | 1987-10-31 | 1989-05-15 | ||
| JPH01316365A (ja) * | 1988-03-24 | 1989-12-21 | Shikoku Chem Corp | １−ベンジルイミダゾール化合物、該化合物の合成方法及び該化合物を用いるポリエポキシ樹脂の硬化方法 |
-
1978
- 1978-10-18 IE IE2067/78A patent/IE47749B1/en unknown
- 1978-10-18 IT IT51570/78A patent/IT1109321B/it active
- 1978-10-18 FI FI783175A patent/FI783175A7/fi not_active Application Discontinuation
- 1978-10-18 CA CA313,653A patent/CA1111433A/en not_active Expired
- 1978-10-18 JP JP12830378A patent/JPS5488268A/ja active Granted
- 1978-10-18 MC MC781335A patent/MC1221A1/xx unknown
- 1978-10-18 DE DE19782845406 patent/DE2845406A1/de not_active Withdrawn
- 1978-10-18 DK DK464278A patent/DK464278A/da not_active Application Discontinuation
- 1978-10-18 ZA ZA785863A patent/ZA785863B/xx unknown
- 1978-10-18 AT AT0747378A patent/AT370095B/de not_active IP Right Cessation
- 1978-10-18 AU AU40824/78A patent/AU522055B2/en not_active Expired
- 1978-11-02 IL IL55858A patent/IL55858A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5488268A (en) | 1979-07-13 |
| AU4082478A (en) | 1980-04-24 |
| DK464278A (da) | 1979-04-20 |
| ZA785863B (en) | 1980-05-28 |
| AU522055B2 (en) | 1982-05-13 |
| IE47749B1 (en) | 1984-06-13 |
| DE2845406A1 (de) | 1979-05-03 |
| IT7851570A0 (it) | 1978-10-18 |
| AT370095B (de) | 1983-02-25 |
| IT1109321B (it) | 1985-12-16 |
| CA1111433A (en) | 1981-10-27 |
| MC1221A1 (fr) | 1979-07-20 |
| ATA747378A (de) | 1982-07-15 |
| IL55858A (en) | 1982-09-30 |
| IE782067L (en) | 1979-04-19 |
| JPS6233227B2 (enrdf_load_stackoverflow) | 1987-07-20 |
| IL55858A0 (en) | 1979-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7809529A (nl) | Imidazoolderivaten. | |
| FI783170A7 (fi) | Imidazolinderivat | |
| FI790314A7 (fi) | Imidazolderivat och deras salter deras synteser och mellanprodukter och farmaceutiska preparat | |
| NL7803432A (nl) | Aceetamidederivaten. | |
| NO784329L (no) | Stilbenderivater. | |
| FI783189A7 (fi) | Alkanoylprolin-derivat och deras homologer, deras framstaellning och anvaendning | |
| NL7803296A (nl) | Cyclohexaandionderivaten. | |
| NL7805344A (nl) | Aminoalkylbenzeenderivaten. | |
| FI783751A7 (fi) | Peptider, deras framstaellningsfoerfarande och dessa innehaollande terapeutiska blandningar | |
| NL7800262A (nl) | Oxazolinoazetidine derivaten. | |
| SE7808059L (sv) | Forfarande for framstellning av 1,2,4-triazin-5-on-derivat | |
| FI780565A7 (fi) | Foerfarande foer framstaellning av d 1-5-metyltetrahydrofolsyra och salter daerav | |
| DD135346A5 (de) | Imidazol-derivate | |
| FI783175A7 (fi) | Imidazol-derivat och salter daerav, deras syntes och mellanprodukter och farmaceutiska preparat | |
| NO781040L (no) | Fungicid preparat. | |
| NL7801708A (nl) | 1-oxadethiacepham-derivaten. | |
| FI783223A7 (fi) | Pyrazinobensoxatsepinderivat, foerfaranden foer deras framstaellning och desamma innehaollande farmaceutiska blandningar | |
| NL7811070A (nl) | 2-imino-imidazolidinederivaten. | |
| NL7801289A (nl) | Oxadiazolopyrimidinederivaten. | |
| NL7808036A (nl) | Nitrosoureum derivaten. | |
| FI780073A7 (fi) | Foerfarande foer framstaellning av n2-arylsulfonyl-l-argininamider och dessas farmaceutiskt laempliga salter | |
| FI783305A7 (fi) | Substantiva diazofaergaemnen, deras framstaellning och anvaendning | |
| NL7801572A (nl) | Gesubstitueerde thioureumderivaten. | |
| NL7807292A (nl) | Prostaglandinederivaten. | |
| NL7806022A (nl) | Benzpyranglycosidederivaten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: THE WELLCOME FOUNDATION, LIMITED |